Amneal, FTC reportedly win order removing Teva inhaler patents from FDA listThe decision comes after the FTC's warnings to drugmakers over the misuse of Orange Book patent listings to wrongly extend patent monopolies on brand-name drugs, per a Reuters report. Alvotech, STADA add to strategic alliance through denosumab partnershipAVT03 is a clinical-stage biosimilar candidate referencing the Prolia/Xgeva medicines for osteoporosis and cancer-related bone loss, respectively. Ahold Delhaize USA inks agreement with Mark Cuban Cost Plus Drug Company The Team Cuban Card is now accepted at Food Lion, Giant Food, The Giant Co., Hannaford and Stop & Shop Pharmacy locations. Amphastar receives FDA OK for generic ProAir HFA Amphastar’s albuterol sulfate inhalation aerosol is for the treatment or prevention of bronchospasm in certain patients with reversible obstructive airway disease. Alvotech announces strategic refinancing agreement The financing will enable Alvotech to improve cost of capital, address upcoming debt maturities in 2025 and enhance its financial flexibility. Amneal expands injectables portfolio with 6 new therapies With these new launches, Amneal now provides 13 injectables that are on the ASHP shortage list. Alembic launches generic Retin-A Cream Tretinoin cream 0.1% is indicated for topical application in the treatment of acne vulgaris. Amphastar announces additional $50M increase to its Share Buyback Program The primary goal of the program is to offset dilution created by the company's equity compensation programs. Lupin receives tentative FDA OK for generic Prevymis, launches generic Vibramycin Letermovir tablets had a market value of roughly $314 million, while doxycycline for injection had a market value of approximately $48 million. FDA approves Amgen's Soliris biosimilar Amgen’s Bkemv is the first interchangeable biosimilar to Soliris to treat certain rare diseases. First Previous 30 31 32 33 34 Next Last
